[This review was originally posted at the Nieman Journalism Lab Purchase Zoloft, on Dec. 10, 2010.]

Only one topic really grabbed everyone's attention this week in future-of-news circles (and most of the rest of the world, too): WikiLeaks. To make the story a bit easier to digest, I've divided it into two sections — the crackdown on WikiLeaks, and its implications for journalism. Buy no prescription Zoloft online, Attacks and counterattacks around WikiLeaks: Since it released 250,000 confidential diplomatic cables last week, WikiLeaks and its founder, Julian Assange, have been at the center of attacks by governments, international organizations, and private businesses. The forms and intensity they've taken have seemed unprecedented, buy Zoloft online no prescription, though Daniel Ellsberg said he faced all the same things when he leaked the Pentagon Papers nearly 40 years ago.

Here's a rundown of what's happened since late last week: Both Amazon and the domain registry EveryDNS.net booted WikiLeaks, leaving it scrambling to stay online, Purchase Zoloft. (Here's a good conversation between Ethan Zuckerman and The Columbia Journalism Review on the implications of Amazon's decision.) PayPal, the company that WikiLeaks uses to collect most of its donations, cut off service to WikiLeaks, too. PayPal later relented, Low dose Zoloft, but not before botching its explanation of whether U.S. government pressure was involved.

On the government side, the Library of Congress blocked WikiLeaks, and Assange surrendered to British authorities on a Swedish sexual assault warrant (the evidence for which David Cay Johnston said the media should be questioning) and is being held without bail. Slate's Jack Shafer said the arrest could be a blessing in disguise Purchase Zoloft, for Assange.

WikiLeaks obviously has plenty of critics: Christopher Hitchens called Assange a megalomaniac who's "made everyone complicit in his own private decision to try to sabotage U.S. foreign policy," and U.S, discount Zoloft. Sens. Dianne Feinstein and Joe Lieberman called for Assange and The New York Times, respectively, to be prosecuted via the Espionage Act. But WikiLeaks' many online defenders also manifested themselves this week, too, as hundreds of mirror sites cropped up when WikiLeaks' main site was taken down, Zoloft maximum dosage, and various online groups attacked the sites of companies that had pulled back on services to WikiLeaks. By Wednesday, it was starting to resemble what Dave Winer called "a full-out war on the Internet."

Search Engine Land's Danny Sullivan looked at the response by WikiLeaks' defenders to argue that WikiLeaks will never be blocked, and web pioneer Mark Pesce said that WikiLeaks has formed the blueprint for every group like it to follow, Purchase Zoloft. Many other writers and thinkers lambasted the backlash against WikiLeaks, including Reporters Without Borders, Business Insider's Henry Blodget, Roberto Arguedas at Gizmodo, BoingBoing's Xeni Jardin, Wired's Evan Hansen, where can i buy Zoloft online, and David Samuels of The Atlantic.

Four defenses of WikiLeaks' rights raised particularly salient points: First, NYU prof Clay Shirky argued that while WikiLeaks may prove to be damaging in the long run, democracy needs it to be protected in the short run: "If it’s OK for a democracy to just decide to run someone off the internet for doing something they wouldn’t prosecute a newspaper for doing, the idea of an internet that further democratizes the public sphere will have taken a mortal blow." Second, CUNY j-prof Jeff Jarvis said that WikiLeaks fosters a critical power shift from secrecy to transparency. Zoloft blogs, Finally, GigaOM's Mathew Ingram and Salon's Dan Gillmor made similar points about the parallel between WikiLeaks' rights and the press's First Amendment rights. Whether we agree with them or not, Assange and WikiLeaks are protected under the same legal umbrella as The New York Times, they argued, and every attack on the rights of the former is an attack on the latter's rights, too. Purchase Zoloft, "If journalism can routinely be shut down the way the government wants to do this time, we'll have thrown out free speech in this lawless frenzy," Gillmor wrote.

—

WikiLeaks and journalism: In between all the attacks and counterattacks surrounding him, buy Zoloft from mexico, Julian Assange did a little bit of talking of his own this week, too. He warned about releasing more documents if he's prosecuted or killed, including possible Guantánamo Bay files. He defended WikiLeaks in an op-ed in The Australian. He answered readers' questions at The Guardian, Zoloft canada, mexico, india, and dodged one about diplomacy that started an intriguing discussion at Jay Rosen's Posterous. When faced with the (rather pointless) question of whether he's a journalist, he responded with a rather pointless answer, Purchase Zoloft.

Fortunately, plenty of other people did some deep thinking about what WikiLeaks means for journalism and society. (The Atlantic's Alexis Madrigal has a far more comprehensive list of those people's thoughts here.) Former Guardian web editor Emily Bell argued that WikiLeaks has awakened journalism to a renewed focus on the purpose behind what it does, as opposed to its current obsession with the models by which it achieves that purpose. Here at the Lab, USC grad student Nikki Usher listed a few ways that WikiLeaks shows that both traditional and nontraditional journalism matter and pointed out the value of the two working together.

At the Online Journalism Review, Zoloft from canadian pharmacy, Robert Niles said that WikiLeaks divides journalists into two camps: "Those who want to see information get to the public, by whatever means, and those who want to control the means by which information flows." Honolulu Civil Beat editor John Temple thought a bit about what WikiLeaks means for small, local news organizations like his, and British j-prof Paul Bradshaw used WikiLeaks as a study in how to handle big data dumps journalistically. Purchase Zoloft, Also at the Lab, CUNY j-prof C.W. Anderson had some thoughts about this new quasi-source in the form of large databases, Buying Zoloft online over the counter, and how journalists might be challenged to think about it. Finally, if you're looking for some deep thoughts on WikiLeaks in audio form, Jay Rosen has you covered — in short form at PBS MediaShift, and at quite a bit more length with Dave Winer on their Rebooting the News podcast.

—

How porous should paywalls be?: Meanwhile, the paid-content train chugs along, led by The New York Times, australia, uk, us, usa, which is still planning on instituting its paywall next year. The Times' digital chief, Martin Nisenholtz, dropped a few more details this week about how its model will work, again stressing that the site will remain open to inbound links across the web.

But for the first time, Nisenholtz also stressed the need to limit the abuse of those links as a way to get inside the wall without paying, revealing that The Times will be working with Google to limit the number of times a reader can access Times articles for free via its search, Purchase Zoloft. Nisenholtz also hinted at the size of the paywall's target audience, Buy Zoloft from canada, leading Poynter's Rick Edmonds to estimate that The Times will be focusing on about 6 million "heavy users of the site."

Reuters' Felix Salmon was skeptical of Nisenholtz's stricter paywall plans, saying that they won't be worth the cost: "Strengthening your paywall sends the message that you don’t trust your subscribers, or your subscribers’ non-subscriber friends: you’re treating them as potential content thieves." The only way such a strategy would make sense, he said, is if The Times is considering starting at a very high price point, something like $20 a month. Henry Blodget of Business Insider, on the other hand, Zoloft schedule, is warming to the idea of a paywall for The Times.

In other paid-content news: News Corp.'s Times of London, which is running a very different paywall from The New York Times, may have only 54,000 people accessing content behind it, according to research by the competing Guardian. Zoloft dosage, The Augusta (Ga.) Chronicle announced it's launching an metered model powered by Steve Brill's Press+, a plan Steve Yelvington defended and Matthew Terenzio questioned. Purchase Zoloft, While one paid-content plan gets started, another one might be coming to an end: Newsday is taking its notoriously unsuccessful paywall down through next month, and several on Twitter guessed that the move would become permanent. One news organization that's not going to be a pioneer in paid online news: The Washington Post, as Post Co. CEO Don Graham said at a conference this week.

—

Reading roundup: Other than the ongoing WikiLeaks brouhaha, it's been a relatively quiet week on the future-of-news front. Here's a bit of what else went on:

— Web guru Tim O'Reilly held his News Foo Camp in Arizona last weekend, and since it was an intentionally quiet event, it didn't dominate the online discussion like many such summits do. Still, there were a few interesting post-Newsfoo pieces for the rest of us to chew on, including a roundup of the event by TBD's Steve Buttry, Alex Hillman's reflections, and USC j-prof Robert Hernandez's thoughts on journalists' calling a lie a lie, Purchase Zoloft.

— A few iPad bits: News media marketer Earl Wilkinson wrote about a possible image problem with the iPad, All Things Digital's Peter Kafka reported on the negotiations between Apple and publishers on iTunes subscriptions, and The New York Times' David Nolen gave some lessons from designing election results for the iPad.

— The Guardian's Sarah Hartley interviewed former TBD general manager Jim Brady about the ambitious local online-TV project, and Lost Remote's Cory Bergman looked at TBD and other local TV online branding efforts.

— Advertising Age's Ann Marie Kerwin has an illuminating list of 10 trends in global media consumption.

— Finally, two good pieces from the Lab: Harvard prof Nicholas Christakis on why popularity doesn't equal influence on social media, and The New York Times' Aron Pilhofer and Jennifer Preston provided a glimpse into how one very influential news organization is evolving on social media.

Similar posts: Cephalexin No Rx. Buy Retin A No Prescription. Order Diflucan. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Purchase Zoloft. Purchase Zoloft. Purchase Zoloft. Zoloft results. Zoloft pics. Buy Zoloft from mexico.

[This review was originally posted at the Nieman Journalism Lab Synthroid For Sale, on Dec. 3, 2010.]

We're covering two weeks instead of the usual one in this review, so there's a ton to pack in here. I'll try to zip through it a little more quickly than usual.

What to make of WikiLeaks: WikiLeaks made its third big document drop since this summer this week, releasing about 250,000 confidential diplomatic cables. Here's coverage by The New York Times, Synthroid duration,  The Guardian, Der Spiegel, and a roundup by The Columbia Journalism Review. Time talked to WikiLeaks' Julian Assange about the leak, and Forbes published an interview and long piece about Assange's next target — corporate America, Synthroid For Sale.

As for the leak itself, The Guardian detailed the documents' path from the alleged leaker, U.S. soldier Bradley Manning, to Assange, to a Guardian reporter. Yahoo's Michael Calderone looked at The Times' editorial process with the cables, purchase Synthroid for sale, including the revelation that they got them from The Guardian, not WikiLeaks. The Wall Street Journal and CNN both declined to sign agreements with WikiLeaks to see the documents in advance, and The Journal examined news orgs' decisions on whether or not to publish. The Times explained its own publishing decision, then (quite eloquently) responded to readers' objections. Synthroid For Sale, The reaction against WikiLeaks was quicker and harsher than those following each of its last two leaks. Before the documents were released, its site was hacked, the U.S. Purchase Synthroid online no prescription, and British governments issued pre-emptive condemnations, and senators called for WikiLeaks to be prosecuted. After the release, the Obama administration said it was indeed pursuing a criminal investigation, Interpol revealed it has put out a call for Assange's arrest (ostensibly for his rape accusations), and Amazon booted WikiLeaks from its servers under pressure from U.S. Sen. Joe Lieberman, Synthroid For Sale.

WikiLeaks' actions left many journalists and media observers divided: An Economist blogger accused WikiLeaks of degenerating into gossip, and even Wikipedia co-founder Larry Sanger called them enemies of the American people. Assange and WikiLeaks had their defenders, purchase Synthroid, too: Slate's Jack Shafer praised them for puncturing "the prerogative of secrecy," and another Economist blogger made a similar argument. The Guardian's Simon Jenkins noted that "the job of the media is not to protect power from embarrassment." Meanwhile, Northeastern j-prof Dan Kennedy wrestled with the balance between transparency and secrecy.

Others' primary concern was not value judgments, but classification. Is WikiLeaks  Synthroid For Sale, espionage. Journalism? Radically open government? Or, as CUNY j-prof C.W. Purchase Synthroid online, Anderson argued, is it a facilitator of real-time history documentation. NYU j-prof Jay Rosen hashed out his thoughts on WikiLeaks as a stateless news organization on video, concluding, "The watchdog press died, and what we have is WikiLeaks instead." Paul Balcerak wondered why WikiLeaks gets so much more attention than the press's own reporting.

If you really want to spend the weekend pondering the meaning of WikiLeaks, it's best to start with two posts: Some incisive questions by Salon's Dan Gillmor, and a brilliant post by Aaron Bady sifting through Assange's own words to determine his motivations behind WikiLeaks' radical transparency.

—

Rupert's big tablet splash: We've heard bits and pieces about Rupert Murdoch's planned tablet-based national news publication, but we got the first substantive report on the subject two weeks ago from Women's Wear Daily, Synthroid For Sale. Among the key details: It's going by The Daily, Synthroid price, coupon, it has a staff of 100, it'll cost 99 cents a week, and it'll come out once a day. The New York Observer gave us some more information about the publication's design (it's text-first and will be published overnight, but apparently looks pretty cool). Other tidbits: John Gruber at Daring Fireball heard that it'll pioneer a new app subscription API from Apple, and New York's Gabriel Snyder said it will have a centrist editorial outlook.

The reasons why this project is getting so much pre-launch attention seem pretty readily evident: Murdoch, Synthroid mg, original tablet news org, iPad news subscriptions, you know the rest. As The Columbia Journalism Review noted Synthroid For Sale, , what's new about this publication is that it won't even have a website. The initial response from the media-watching world was predominantly negative, with skepticism coming from The New York Times' David Carr, Gawker's Ryan Tate, Scott Rosenberg, Sam Diaz of ZDNet, GigaOM's Mathew Ingram, Fast Company's Kit Eaton, comprar en línea Synthroid, comprar Synthroid baratos, The Guardian's Emily Bell, and paidContent's Andrew Wallenstein.

Many of those critics made similar points, so here's a roundup of the main ones: 1) It's trying to impose slow print-think onto the speed-oriented world of mobile media (this is Rosenberg's main point); 2) The fact that it won't have inbound or outbound links means it can't share in the virality that makes news on the Web work; 3) The folks on board don't exactly seem like the tech revolutionaries they might need to be (Wallenstein's main point); and 4) How many people are actually going to pay for this, and can it really cover The Daily's costs. (Carr's main objection)

Several of those people also noted a few factors in Murdoch's favor: Carr argued that people will be more likely to pay for news in an app world than on the web, and both Tate and Eaton noted that Apple's Steve Jobs (who is reported to be tied to the project) is a pretty powerful guy with a history of success in ventures like these. We got a few good suggestions for Murdoch's project, Doses Synthroid work, too: TechCrunch's Erick Schonfeld said to make it local, real-time, and social; Frederic Filloux wanted it speedy, simple, beyond Apple, and with adjustable pricing; and at paidContent, Nic Newman wanted to see a mixture of free and paid content.

—

Designing apps for tablets and mobile media: Murdoch isn't the only one with a big new tablet app to unveil: Yahoo's Joe Pompeo summarized two others — mini-magazines called Nomad Editions and a new iPad magazine by Virgin called Project, Synthroid For Sale. Of those, Project, announced Tuesday, ordering Synthroid online, got a bit more attention. PaidContent had some details about its video cover and "living magazine" mindset, and All Things Digital's Peter Kafka pointed out the magazine's rather intimidating instruction page, though David Carr told NPR it's still pretty magazine-like.

Also in the process of launching: Next Issue Media, a joint venture by several magazine magnates, will launch its digital newsstand early next year and gave some details to MediaWeek, and Swedish publisher Bonnier, Synthroid photos, whose Mag+ everyone loved, is expanding into News+. Meanwhile, the Financial Times' iPad app is doing well, but The Guardian's Dan Sabbagh remained skeptical that most newspapers' iPad apps will be able to stand out among the sea of more enjoyable apps.

A couple more smart thoughts on mobile media: PaidContent founder Rafat Ali talked about Synthroid For Sale, designing for touchscreens, and Poynter's Damon Kiesow argued that smartphones are fundamentally a mobile device, while the iPad is a leisure device, so their apps can't be imposed onto each other: "To fully serve and engage an audience, an app needs to target one distinctive strength — either location or leisure — and make the content and experience fit that use."

—

Gawker grows beyond the blog: In advance of its coming overhaul early next year, Gawker head Nick Denton wrote a manifesto explaining why the network of sites is going beyond the blog format (his post at the previous link is in the sites' new design). Denton said he's discovered the new formula for online media success: Not so much Gawker's former trademark snarky meta-analysis, but a few huge juicy scoops accompanied by a steady stream of aggregation, all with a visual bent. He extended the model to include advertising and branding as well.

Reuters' Felix Salmon responded with a meticulous analysis of Gawker's new direction, Synthroid description, noting that while Denton was the first person to make blogging into "a large-scale commercial venture," he's now aggressively dumping blogging's defining reverse-chronological format. Ron Mwangaguhunga of eMedia Vitals compared Gawker's new model with a TV business model, and Anil Dash said that while Gawker is still a blog, it's borrowing Twitter's design that emphasizes both content and the stream of news. "By allowing that flow to continue regardless of which particular piece of embedded content has caught your eye, Gawker and Twitter are just showing the vibrancy and resilience of the format."

—

Why Twitter matters: Speaking of Twitter, Guardian editor Alan Rusbridger offered a stirring defense of Twitter's meaning for journalism as part of a lecture on the state of the Fourth Estate. His list of 15 reasons Twitter matters covers most everything: Reporting, conversation, aggregation, search, marketing, authority, writing, Synthroid For Sale. Likewise, Synthroid street price, GigaOM's Mathew Ingram argued that Twitter's real cultural power "could well be that it is the simplest, the easiest and arguably one of the most efficient forms of mass publishing — or at least micro-publishing — ever invented."

Later, Ingram took Twitter co-founder Biz Stone's apparently off-the-cuff statement that Twitter could develop a news network as an opportunity to think about how news orgs could filter Twitter into a usable crowdsourced newswire. And MediaBistro talked with Canada's National Post to get a sense of how one major newspaper uses Twitter.

—

Business-model developments and discussion: A few notes on the ever-evolving paid-content front: At least two more news organizations are using the Press+ system of Steve Brill's Journalism Online for their online revenue goals — ProPublica, which is using it to solicit donations online, and Oklahoma State's Daily O'Collegian, which will charge outside-the-area readers. Over at The Guardian, Cory Doctorow examined The Times of London's paywall numbers, and CrunchGear's Devin Coldewey thought out loud about a possible online paid-content system, order Synthroid from United States pharmacy.

Meanwhile, British journalist Kevin Anderson wrote a post arguing that value-added journalism has to be developed with specific revenue streams in mind. Howard Owens of The Batavian countered Synthroid For Sale, that would-be entrepreneurial journalists need to focus more on basic local events journalism than "adding value" or analytical journalism, and TBD's Steve Buttry tried to bring the two perspectives together.

—

Reading roundup: Here's what else you should see this week, in the quickest-hit form I can give it to you:

— A British court upheld a stipulation that news organizations can charge paid online news monitoring agencies for using their content. The Telegraph, TechCrunch Europe, and the Press Gazette explain why it's bad news for aggregators.

— No less an authority than World Wide Web inventor Tim Berners-Lee joined the chorus of people extolling the value of data journalism during a panel. A somewhat related debate broke out when Mark Luckie opined on the myths about digital journalism skills. Discount Synthroid, Journalist Andy Boyle disputed Luckie's claims about what new-media skills journalists need (and don't need) to know, and j-prof Mindy McAdams and journalist Brian Manzullo chimed in. Anthony DeBarros and Robert Hernandez turned the discussion toward data journalism, with Hernandez asserting that programming doesn't replace the story. That got Michelle Minkoff kind of riled up, Synthroid For Sale.

— The New York Times ran an article looking at the ways technology is creating increased distractions for young people, which was met by smart rebuttals by Duke prof Cathy Davidson and the Lab's own Megan Garber.

— Also at the Lab: USC prof Henry Jenkins on his concept of "spreadable" media.

— Mashable's Vadim Lavrusik wrote a great roundup of what's going on at the intersection of investigative journalism and social media.

— Finally, if you're looking for a single document to answer the question, "How should newspapers adapt to this new media environment?" you can't do much better than John Paton's presentation on how he's turned around the Journal Register Co. It's brilliant.

Similar posts: Cipro Price. Armour Dosage. Purchase Synthroid. Japan, craiglist, ebay, overseas, paypal. Buy Glucophage from mexico. Flagyl without prescription.
Trackbacks from: Synthroid For Sale. Synthroid For Sale. Synthroid For Sale. Buy generic Synthroid. Synthroid australia, uk, us, usa. Get Synthroid.

[This review was originally posted at the Nieman Journalism Lab Buy Glucophage No Prescription, on Nov. 19, 2010.]

An unpopular marriage: As I briefly noted in last week's review, the big story this week was, not surprisingly, Newsweek's merger with Tina Brown and Barry Diller's website The Daily Beast. The New York Observer, which broke the story, buying Glucophage online over the counter, had most of the newsy details — merged websites under The Daily Beast, unspecified layoffs to come, etc. — as well as the story of how the deal went down.

The Daily Beast's own Howard Kurtz had some notes on what the new organization would look like, led by Brown's assertion that whatever the new Newsweek will be, Glucophage recreational, it won't be the newsmagazine format. As The New York Times' Evelyn Rusli observed, the key asset in this deal may not be either property but instead Brown, one of the U.S.' most prominent magazine editors, Buy Glucophage No Prescription. The Wall Street Journal had more notes on Brown, and Slate's Jack Shafer dished out some advice for her.

Just about the only media figure who voiced any sort of excitement about the deal was Arianna Huffington; everyone else's responses ranged from indifference to revulsion. The New York Times' David Carr laid his derision on thick, saying the deal "marries two properties that have almost nothing in common other than the fact that they both lose lots of money." NYU professor Clay Shirky called it a farcical reprise of the AOL-Time Warner bomb. TechCrunch's Erick Schonfeld warned the two companies not to combine their brands (and it appears they won't, except online), Glucophage without prescription.

The Wall Street Journal summed up the doubters' concerns well with a list of four reasons Buy Glucophage No Prescription, for concern: Joint ventures are tough, media joint ventures are tougher, it's headed by strong-willed personalities, and it's a merger of two companies that are losing money. The last point gained the most traction, building on media reports (which Scott Rosenberg questioned) that have Newsweek on pace to lose $20 million this year and The Daily Beast on track to lose $10 million (though it was supposedly expected to turn a profit within two years). Business Insider's Henry Blodget joined the Journal in wondering how they'd make money together, and Forbes' Jeff Bercovici asked a good question: If your media venture is on track to profitability, why would you want to tie yourself to a business that's gone nowhere but down?

There were a couple of possible answers: First, as The New York Times reported, Glucophage price, the Beast's Diller has developed a sudden affinity for print publications. Also, Mediaite's Colby Hall noted that with as much content as the Beast produces, Newsweek's costs could drop pretty quickly, and Advertising Age said advertisers could be attracted by simple novelty of the new organization.

The other big piece of the deal is the fact that it will likely mean the death of Newsweek.com, despite the fact that has a far larger audience than The Daily Beast. The website's staff members are nervously awaiting their fate, but in the meantime took to Tumblr to mount a defense of Newsweek.com, praising its work while saying it has "always remained an ugly stepchild to its print grandparents, who were too busy burning money to notice." Former Newsweek.com staffer Mark Coatney chimed in, wondering what would happen to Newsweek's SEO and content deals without its own site, Buy Glucophage No Prescription. Reuters' Felix Salmon also agreed, purchase Glucophage online, saying the shutdown only makes sense as a power grab by Brown. But Advertising Age and GigaOM defended the move, saying the Beast's traffic is more valuable than Newsweek's.

—

Don't call it an email killer: Facebook made a big announcement this week, unveiling its new quasi-email, quasi-chat message system, Online buy Glucophage without a prescription,  Facebook Messages. (Want to know what it looks like. Search Engine Land has you covered.) The message we heard repeatedly Buy Glucophage No Prescription, from Facebook was that Messages is not a rival to email services like Google's Gmail. And why was that. Well, because it spent most of the weekend being hyped as a "Gmail killer." And the reason it's such a threat to email, said Charlene Li and ReadWriteWeb, is precisely because it's a lot more than email: It's the convergence of chat, email and text messaging; archived communications by friend; and a "social inbox." The gadget blog Gizmodo said we'll be giving up traditional email for it because we're all already using Facebook's interface and because it should be able to sort what's important from what's not, Glucophage no prescription.

But another Gawker blog, Lifehacker, said we shouldn't give up email for Facebook Messages, because it's meant to work with email, not like email. In addition, Glucophage results, anything you say there can't be moved elsewhere. Others were also skeptical, for a variety of reasons: Silicon Alley Insider's Matt Rosoff and the Houston Chronicle Dwight Silverman said this isn't unified communications, but just another way to get hardcore users to spend more time on Facebook, Buy Glucophage No Prescription. GigaOM's Mathew Ingram argued that many people won't use it as an email supplement if it doesn't connect to their existing email accounts. The Guardian talked to an analyst who said Facebook can't handle the task of using all of its data to optimize social messaging. Then there's the privacy issue: Salon's Dan Gillmor said we should be uncomfortable about putting all of our communications into the hands of a single company, especially Facebook.

There were three other thoughtful perspectives on what Facebook Messages means that stood out: Om Malik of GigaOM saw Messages as a critical step for Facebook in helping us stay in touch with our most intimate friends, as opposed to the more distant "second-order" friends it's been specializing in. Buy Glucophage No Prescription, And though he was off about the shape Messages would take, Nick O'Neill of All Facebook aptly placed Messages within a long-running battle between Facebook and Google for online authority.

Finally, buy Glucophage online no prescription, in a post at the Lab, Ken Doctor called for news organizations to embrace the philosophy behind Facebook Messages: "It’s about simplification, about interconnection, about consolidation." Meanwhile, in other much-less-covered email-related news: AOL announced it's relaunching its own email service, a story TechCrunch rather comically broke last Friday. Online buying Glucophage hcl, —

Yahoo goes deeper into original content: Yahoo dived deeper into the original-content pool this week with two moves: First, it added three new blogs to its seven-month-old The Upshot, building a network of originally reported news blogs. The new sites will focus on politics, national news, and media. CNN noted that the new group is being headed by a veteran of Talking Points Memo and quoted Yahoo News head Mark Walker as describing it as Yahoo's biggest original-content push yet: "Pure aggregation will only get you so far, even if you're really good at it."

Yahoo also completed its integration of Associated Content, Glucophage brand name, the content farm it bought in May, by relaunching it as the Yahoo Contributor Network. Through the network, Yahoo plans to post at least 2,000 articles of search engine-friendly content a day, paying its 400,000 contributors a small fee upfront, followed by bonused based on pageviews, Buy Glucophage No Prescription. Kara Swisher of All Things Digital was skeptical of the plan.

—

Some eye-opening iPad stats: We got a few more pieces of data on iPad use in the past week, including some quick, interesting stats from The Wall Street Journal showing that iPad use jumps in the evening, Effects of Glucophage, while computer use drops. (Smart phone is relatively steady throughout the day.) This seems to correlate with what many have suspected about the iPad — that it's being used as more of a leisure device than phones or computers.

Business Insider had quite a few more fascinating stats from its survey of iPad owners, finding, among other things, that most iPad owners are using their iPads more than when they first got the device, 30% are using it as their primary computer, they're spending as much time with it as they are their laptops, is Glucophage safe, and about equal numbers of people use the browser and apps to read news. Poynter's Damon Kiesow isn't reading much into the data Buy Glucophage No Prescription, , but he did find it surprising that about a third are reading news primarily on apps, considering how few news orgs have them out right now. That's good news for major media outlets, he said, though it doesn't mean much for the little guys.

Meanwhile, News Corp.'s James Murdoch said he thinks news apps for mobile devices like the iPad cannibalize newspaper sales, Glucophage forum, something Reuters' Felix Salmon wasn't sure about, and Poynter's Kiesow wasn't buying without seeing some data. News Corp., by the way, is reported to be close to launching its much-talked-about tablet news publication, and The Economist dropped its own iPad app this week.

—

Google News' crediting experiment: One cool little story worth highlighting: Google News announced it's introducing two tags for articles that will help indicate which articles were the first to report a story and which articles are essentially the same story on different sites. It's an experiment, as the Lab's Megan Garber noted, in finding out how willing news organizations are to give online credit where credit is due, Buy Glucophage No Prescription. As Search Engine Land's Matt McGee pointed out, ordering Glucophage online, they're based on the honor system, so there's nothing to stop spammers (or legit news organizations) from misusing the tags. CUNY j-prof C.W. Anderson wondered if the tags might provide some new research opportunities for scholars.

—

Reading roundup: Here's everything else worth taking a look at before you hit the weekend:

— Over at the National Sports Journalism Center, Jason Fry has written a wonderful column on the importance of the link to sports journalism, and it goes for all journalism as well. Buy Glucophage No Prescription, Elsewhere, Terry Heaton wrote about the value of the link in online advertising, a notion The Batavian's Howard Owens took issue with.

— A few paid-content tidbits: Connecticut's Valley Independent Sentinel is the latest local newspaper to make use of Journalism Online's Press+ paid-content system, The Times of London is partnering with a mobile broadband provider for a free-access offer at its website, and two new-media companies are working on an online news "EZ Pass."

— A couple pieces from last week I missed: Mashable's Vadim Lavrusik and Eastern Illinois j-prof Bryan Murley both urged j-schools to push some more boundaries in their teaching of news and technology.

— Weekly fuel for the pessimists among us: Poynter's Rick Edmonds on the signs that newspapers are still failing financially, and the nonprofit news site The Washington Independent announced it's closing up shop.

— And in the food-for-thought category: Jonathan Stray on the real value of social news, and CUNY j-prof C.W. Anderson at the Lab on journalism and online community. "We can’t will authentic community into being. It sort of sneaks up on us. And just as quickly — as soon as we turn our heads — it’s gone.".

Similar posts: Synthroid Cost. Lipitor No Rx. Purchase Retin A. Glucophage from canadian pharmacy. Where can i buy cheapest Flagyl online. Glucophage photos.
Trackbacks from: Buy Glucophage No Prescription. Buy Glucophage No Prescription. Buy Glucophage No Prescription. Is Glucophage safe. Glucophage coupon. Purchase Glucophage online no prescription.

[This review was originally posted at the Nieman Journalism Lab Buy Lipitor No Prescription, on Nov. 12, 2010.]

Olbermann and objectivity: Another week, another journalist or pundit disciplined for violating a news organization's codes against appearances of bias: This week (actually, late last week) it was Keith Olbermann, liberal commentator for the liberal cable news channel MSNBC, suspended for donating money to Democratic congressional candidates, in violation of NBC News policy. Lipitor use, Olbermann issued an apology (though, as Forbes' Jeff Bercovici noted, it was laced with animus toward MSNBC), and returned to the air Tuesday. There were several pertinent peripheral bits to this story — Olbermann was reportedly suspended for his refusal to apologize on air, it's unclear whether NBC News' rules have actually applied to MSNBC, numerous other journalists have done just what Olbermann did — but that's the gist of it.

By now, we've all figured out what happens next: Scores of commentators weighed in on the appropriateness (or lack thereof) of Olbermann's suspension and NBC's ban on political contributions, Lipitor blogs. The primary arguments boiled down to the ones expressed by Poynter's Bob Steele and NYU's Jay Rosen in this Los Angeles Times piece: On one side, donating to candidates means journalists are acting as political activists, which corrodes their role as fair, independent reporters in the public interest, Buy Lipitor No Prescription. On the other, being transparent is a better way for journalists to establish trust with audiences than putting on a mask of objectivity.

Generally falling in the first camp are fellow MSNBC host Rachel Maddow ("We're a news operation. The rules around here are part of how you know that."), Northeastern j-prof Dan Kennedy (though he tempered his criticism of Olbermann in a second post), and The New York Times' David Carr ("Why merely annotate events when you can tilt the playing field?"). The Columbia Journalism Review was somewhere in the middle, Lipitor pics, saying Olbermann shouldn't be above the rules, but wondering if those rules need to change.

There were plenty of voices Buy Lipitor No Prescription, in the second camp, including the American Journalism Review's Rem Rieder, Michael Kinsley at Politico, and Lehigh j-prof Jeremy Littau all arguing for transparency.

Slate media critic Jack Shafer used the flap to urge MSNBC to let Olbermann and Maddow fly free as well-reported, openly partisan shows in the vein of respected liberal and conservative political journals. Jay Rosen took the opportunity to explain his pet phrase "The view from nowhere," which tweaks traditional journalism's efforts to "advertise the viewlessness of the news producer" as a means of gaining trust. He advocates transparency instead, and Terry Heaton provided statistics showing that the majority of young adults don't mind journalists' bias, as long as they're upfront about it.

On The Media's Brooke Gladstone summed up the issue well: "Ultimately, kjøpe Lipitor på nett, köpa Lipitor online, it’s the reporting that matters, reporting that is undistorted by attempts to appear objective, reporting that calls a lie a lie right after the lie, not in a box labeled “analysis,” reporting that doesn't distort truth by treating unequal arguments equally."

—

Commodify your paywall: We talked quite a bit last week about the new numbers on the paywall at Rupert Murdoch's Times of London, and new items in that discussion kept popping up this week. The Times released a few more details (flattering ones, Lipitor mg, naturally) about its post-paywall web audience. Among the most interesting figures is that the percentage of U.K.-based visitors to The Times' site has more than doubled since February, rising to 75 percent, Buy Lipitor No Prescription. Post-paywall visitors are also visiting the website more frequently and are more wealthier, according to News Corp.

Of course, the overall number of visitors is still way down, and the plan continued to draw heat. In a wide-ranging interview on Australian radio, Guardian editor Alan Rusbridger expressed surprise at the fact that The Times' print circulation dropped as their print-protectionist paywall went up. That, Lipitor dangers, he said, "suggests to me that we overlook the degree to which the digital forms of our journalism act as a kind of sort of marketing device for the newspapers." ResourceWebs' Evan Britton gave five reasons why news paywalls won't work, and Kachingle founder Cynthia Typaldos argued that future news paywalls will be tapping into a limited pool of people willing to pay for news on the web, squeezing each other out of the same small market.

Clay Shirky used The Times' paywall as a basis for some smart thoughts Buy Lipitor No Prescription, about why newspaper paywalls don't work in general. The Times' paywall represents old thinking, Shirky wrote (and the standard argument against it has been around just as long), but The Times' paywall feels differently because it's being taken as a "referendum on the future." Shirky said The Times is turning itself into a newsletter, Buy Lipitor without prescription, without making any fundamental modifications to its product or the basic economics of the web. "Paywalls do indeed help newspapers escape commodification, but only by ejecting the readers who think of the product as a commodity. This is, invariably, most of them," he wrote.

—

A conversation about blogging, voice, and ego: A singularly insightful conversation about blogging was sparked this week by Marc Ambinder, Lipitor canada, mexico, india, who wrote a thoughtful goodbye post at his long-running blog at The Atlantic. In it, Ambinder parsed out differences between good print journalism (ego-free, reliant on the unadorned facts for authority) and blogging (ego-intensive, requires the writer to inject himself into the narrative). With the switch from blogging to traditional reporting, Ambinder said, "I will no longer be compelled to turn every piece of prose into a personal, conclusive argument, to try and fit it into a coherent framework that belongs to a web-based personality called 'Marc Ambinder' that people read because it's 'Marc Ambinder,' rather than because it's good or interesting."

The folks at the fantastically written blog Snarkmarket used the post as a launching point for their own thoughts about the nature of blogging, Buy Lipitor No Prescription. Matt Thompson countered that Ambinder was reducing an incredibly diverse form into a single set of characteristics, taking particular exception to Ambinder's ego dichotomy. Lipitor dosage, Tim Carmody mused on blogging, voice, and authorship; and Robin Sloan defended Ambinder's decision to leave the "Thunderdome of criticism" that is political blogging. If you care at all about blogging or writing for the web in general, make sure to give all four posts a thorough read.

—

TBD's (possible) content/aggregation conflict: The new Washington-based local news site TBD has been very closely watchedsince it was launched in August, and it hit its first big bump in the road late last week, as founding general manager Jim Bradyresigned in quite a surprising move. In a memo Buy Lipitor No Prescription, to TBD employees, TBD owner Robert Allbritton (who also launched Politico) said Brady left because of "stylistic differences" with Allbritton. Despite the falling-out, Lipitor duration, Brady, a washingtonpost.com veteran, spoke highly of where TBD is headed in an email to staff and a few tweets.

But the immediate questions centered on the nature of those differences between Allbritton and Brady. FishbowlDC reported and Business Insider's Henry Blodget inferred from Allbritton's memo that the conflict came down to an original-content-centric model (Allbritton) and a more aggregation-based model (Brady). Brady declared his affirmation of both pieces — he told Poynter's Steve Myers he's pro-original content and the conflict wasn't old media/new media, but didn't go into many more details — but that didn't keep Blodget from taking the aggregation side: The web, My Lipitor experience, he said, "has turned aggregation into a form of content--and a very valuable one at that." Lost Remote's Cory Bergman, meanwhile, noted that while creating content is expensive, Allbritton's made the necessary investments and made it profitable before with Politico.

—

A new iPad app and competitor: There were two substantive pieces of tablet-related news this week: First, The Washington Post released its iPad app, accompanying its launch with a fun ad most everyone seemed to enjoy, Buy Lipitor No Prescription. Poynter's Damon Kiesow wrote a quick summary of the app, which got a decent review from The Post's Rob Pegoraro. For you design geeks, Sarah Sampsel wrote two good posts about the app design process, Lipitor over the counter.

The other tablet tidbit was the release of Samsung's Galaxy Tab, which runs on Google's Android system. Kiesow rounded up a few of the initial reviews from All Things Digital (a real iPad competitor, though the iPad is better), The New York Times (beautiful with some frustrations), Wired (more convenient than the iPad, but has stability problems) and Gizmodo ("a grab bag of neglect, Lipitor from mexico, good intentions and poor execution"). Buy Lipitor No Prescription, Kiesow also added a few initial impressions of the Galaxy's implications for publishers, predicting that as it takes off, it will put pressure on publishers to move to HTML5 mobile websites, rather than developing native apps.

In other tablet news, MediaWeek looked at the excitement the iPad is generating within the media industry, but ESPN exec John Skipper isn't buying the hype, telling MarketWatch's Jon Friedman, "Whenever a new platform comes up, people want to take the old platform and transport it to the new platform." It didn't work on the Internet, Skipper said, it won't work on the iPad either, generic Lipitor.

—

Reading roundup: More thoughtful stuff about news and the web was written this week than most normal people have time to get to. Here's a sample:

— First, a piece of news: U.S. News & World Report announced last week that it's dropping its regular print edition and going essentially online-only, only printing single-topic special issues for newsstand sales. The best analysis on the move was at Advertising Age, Buy Lipitor No Prescription.

— Two great pieces on journalism's collaborative future: Guardian editor Alan Rusbridger in essay form, and UBC j-prof Alfred Hermida in audio and slide form. Where can i buy cheapest Lipitor online, — Poynter published an essay by NYU professor Clay Shirky on "the shock of inclusion" in journalism and the obsolescence of the term "consumer." Techdirt's Mike Masnick added a few quick thoughts of his own.

— Two cool posts on data journalism — an overview on its rise by The Columbia Journalism Review's Lauren Kirchner, and a list of great tools by Michelle Minkoff.

— Finally, two long thinkpieces on Facebook that, quite honestly, I haven't gotten to read yet — one by Zadie Smith at The New York Review of Books, and the other by The Atlantic's Alexis Madrigal. I'm going to spend some time with them this weekend, and I have a feeling you probably should, too.

Similar posts: Order Cephalexin. Buy Zoloft No Prescription. Tramadol Cost. Armour for sale. Where can i buy Cephalexin online. Synthroid without prescription.
Trackbacks from: Buy Lipitor No Prescription. Buy Lipitor No Prescription. Buy Lipitor No Prescription. After Lipitor. Buy Lipitor from canada. Order Lipitor no prescription.

[This review was originally posted at the Nieman Journalism Lab Cipro No Rx, on Nov. 5, 2010.]

Skepticism about News Corp.'s paywall numbers: Future-of-news nerds have been watching the paywall at The Times and Sunday Times of London pretty closely since it was instituted in June, and we finally got our first hard numbers about it this week, from Rupert Murdoch's News Corp. itself. Where can i find Cipro online, The company said 105,000 readers had paid up — either as subscribers or occasional purchasers — for the paper's site or iPad or Kindle apps, with another 100,000 activating free digital accounts that came with their print subscriptions.

To hear News Corp. execs tell it, those numbers marked a huge success, Cipro No Rx. The Times' editor told the BBC he's "hugely encouraged," and Reuters led with the fact that the drop in readership was less than The Times had feared, effects of Cipro. (TBD's Jim Brady called this rhetoric the Spinal Tap defense — "it isn't less popular, its audience is just more selective.") But most everyone outside the company was skeptical. The Guardian's Roy Greenslade and blogger and web activist Cory Doctorow both said we have no idea how successfully this paywall is until we have some more substantive numbers to dig into.

Fortunately, TechCrunch's Erick Schonfeld and Reuters' Felix Salmon found some other relevant data that helps us make a bit more sense of the situation: Schonfeld looked at the Times' sites' traffic dive and concluded that its strategy might be working in the short run but not long-term, Cipro forum, and Salmon pointed to another report that contradicts The Times' apparent theory that print circulation is dropping because people are reading the paper online. Cipro No Rx, "The fact is that insofar as printed newspapers compete with the web, they compete with everything on the web, not just their own sites," Salmon said. "No general-interest publication can prevent its print circulation from declining simply by walling itself off from the web." The New York Observer's Ben Popper saw the numbers as a potential readers-vs.-revenue paradox, and The Guardian's Dan Sabbagh took a stab at what that revenue what be.

Other critics were even more harsh: Lab contributor Ken Doctor said The Times' numbers "don't seem to provide a path to a sustainable business future for the papers, as readers go digital," and GigaOM's Mathew Ingram argued that it's time to officially deem the plans a bust. Former Guardian editor Emily Bell had the most insightful take on the situation, explaining that it indicates that The Times has become a mere pawn in Murdoch's larger media-empire chess game, which means that "the influence game for The Times is up." Once one of the world's leading newspapers, japan, craiglist, ebay, overseas, paypal, "internationally it has no voice, or none to speak of, post the paywall," Bell wrote.

—

Innovation on election night: The midterm elections made Tuesday easily the biggest day of the year in U.S. Cipro alternatives, politics, but it was also an important day for news innovation as well. News organizations were trying out all kinds of flashy new web-related techniques and gizmos, all ably chronicled by Lost Remote's Cory Bergman and by Matt Diaz here at the Lab, Cipro No Rx. The online efforts were led by The New York Times' streaming web video coverage and Twitter visualization, The Washington Post's sponsored Twitter topic, and CNN's web of holograms and magic walls.

Not all of those ambitious new-media efforts hit the mark: The Lab's Megan Garber criticized The Times' and Wall Street Journal's webcasts for simply adopting many of cable news' norms on the web rather than trying something web-native, saying they "had the feeling of trying to be cable news without actually, fast shipping Cipro, you know, being cable news." And Poynter's Regina McCombs had a tepid review of news organizations' election-day iPad apps, giving them an A for effort and probably something around C+ for execution. "By the end of the night I was tired of how much work it was on mobile, and I went old school, Cipro price, " she wrote.

Of course, some things about the press's election coverage never change: Most election-night TV coverage hasn't been terribly helpful in the past, and this year it was marked by uneven analysis masked by excess. Cipro No Rx, And leading up to the elections, the media again lavished the lion's share of its attention on a fringe candidate with little chance to win but plenty of interesting sound bites. Election coverage didn't come without a minor controversy, either, as ABC News invited and then uninvited budding conservative media mogul Andrew Breitbart to participate in its coverage, where to buy Cipro. NYU professor Jay Rosen issued a warning to the mainstream press about welcoming in those who are openly hostile toward it.

—

Ideas, conversations and 'evil' at ONA10: Quite a few folks in the news and tech worlds were headed to Washington last weekend — not for the Jon Stewart/Stephen Colbert rally, but for the Online News Association's annual conference. (OK, Buy Cipro without a prescription, probably for the rally, too.) As usual, the conference featured plenty of nifty speakers and panels, all of which were captured on video and helpfully gathered in one place by Jeff Sonderman. Other sites also created visualizations of the tweets around ONA 2010 and the association's members, Cipro No Rx.

We got several varied but useful summaries of the conference, starting with the Lab's Justin Ellis, who recreated its sessions, Cipro pictures, one by one, through tweets. Craig Silverman of PBS MediaShift was just about as thorough with a roundup of both days' events, focusing largely on the conference's three keynotes covering TBD, NPR, About Cipro, AOL, and WikiLeaks. Poynter's Mallary Jean Tenore listed five key themes from the conference, including the emergence of investigative journalism online and the decline of the "Is this journalism?" debate. The Online Journalism Review's Pekka Pekkala had a review of themes, too, and NPR's Patrick Cooper had some more personal thoughts on the conference, real brand Cipro online, noting the youth and energy of its attendees.

The individual session that drew the most attention was a conversation with NPR CEO Vivian Schiller and AOL CEO Tim Armstrong (liveblogged by Tenore Cipro No Rx, ), in which USC j-prof Robert Hernandez asked Armstrong of AOL's controversial large-scale hyperlocal news initiative, "Is Patch evil?" Armstrong responded by defending AOL's treatment of Patch editors and pointing out its connections with local bloggers in Patch blogs' areas. In a blog post, Hernandez explained his question and gave his thoughts on Armstrong's answer, concluding, "Under the umbrella of 'we care about the community, Cheap Cipro no rx, ' this is a business venture. That's not evil, that's capitalism." Two other sessions worth reading a bit about: Webbmedia's Amy Webb on digital storytelling and several others with advice for would-be journalism entrepreneurs.

—

Twitter adds ads to the stream: Twitter took another step in its integration of advertising into its platform this week with the introduction of Promoted Tweets in users' tweet streams. The tweets will initially be tested only with users of the Twitter application HootSuite, with Twitter selling the ads and HootSuite getting a cut of the revenue, according to Advertising Age, Cipro interactions. The Next Web chatted with HootSuite's Dave Olson about how it will work, and said that Promoted Tweets have successful and relatively inoffensive so far: "Focusing on a good user interaction, instead of simply on the money, Twitter has kept its users and advertisers happy."

ReadWriteWeb's Mike Melanson talked to a few web experts on the potential for user backlash, and they seemed to agree that while Twitter will likely get some initially angry responses, it may end up keeping a satisfied user base if it reacts well to that initial response, Cipro No Rx. As Danny Sullivan of Search Engine Land explained, Twitter's Promoted Tweets were also added to Google search results, lending some credence to Mathew Ingram's assertion at GigaOM that Twitter is in the process of growing up from an awkward teenager into a mature adult right now.

—

Reading roundup: A few good things to read before I send you on your way:

— Two relatively lengthy first-person pieces by journalists who did stints with the content farm Demand Media were published yesterday: A more colorful one by Jessanne Collins at The Awl and a more contextualized one by Nicholas Spangler at The Columbia Journalism Review. Both are worth your time. Cipro no prescription, — Your iPad update for this week: AdWeek looked at why most media companies' iPad apps have been disappointing, and New York and Newsweek magazines released their iPad apps — Newsweek's with a subscription option.

— The Columbia Journalism Review ran a short but sharp editorial urging news organizations to work toward earning authority based on factual reporting, rather than cowering in ideological niches, and Free Press' Josh Stearns connected that idea to the concept of "talking to strangers."

— Finally, three miscellaneous pieces to take a look at: Investigative journalism veteran Charles Lewis' map of the new public-service journalism ecosystem, Jason Fry's list of five places sports departments (and any news department, really) can innovate, and Steve Coll's open letter to the FCC on digital media policy.

Similar posts: Bactrim No Rx. Purchase Diflucan. Lipitor Dosage. Low dose Diflucan. Kjøpe Flagyl på nett, köpa Flagyl online. Bactrim treatment.
Trackbacks from: Cipro No Rx. Cipro No Rx. Cipro No Rx. Where can i find Cipro online. Cipro overnight. Herbal Cipro.